VEGF-R2/Caveolin-1 Pathway of Undifferentiated ARPE-19 Retina Cells: A Potential Target as Anti-VEGF-A Therapy in Wet AMD by Resvega, an Omega-3/Polyphenol Combination
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is one of the main causes of deterioration in vision in adults aged 55 and older. In spite of therapies, the progression of the disease is often observed without reverse vision quality. In the present study, we explored whether, in undifferentiated ARPE-19 retinal cells, a disruption of the VEGF receptors (VEGF-R)/caveolin-1 (Cav-1)/protein kinases pathway could be a target for counteracting VEGF secretion. We highlight that Resvega®, a combination of omega-3 fatty acids with an antioxidant, resveratrol, inhibits VEGF-A secretion in vitro by disrupting the dissociation of the VEGF-R2/Cav-1 complex into rafts and subsequently preventing MAPK activation. Moreover, DNA ChIP analysis reveals that this combination prevents the interaction between AP-1 and vegf-a and vegf-r2 gene promoters. By these pathways, Resvega could present a potential interest as nutritional complementation against AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Nutritional anti-VEGF intervention against wet AMD has been shown to act by preventing MAPK activation in RPE cells [ 54 ], with the involvement of NFκB [ 55 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“Despite an increasing number of reports highlighting the key role of VEGF-A in the development of blood vessels in tumors and other tissues undergoing abnormal angiogenesis [27,28], and the development of new anti-VEGF antibodies to counteract neovascularization, especially in advanced cancers or in ocular diseases (i.”
BackgroundMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467 · cited 1×
“Despite an increasing number of reports highlighting the key role of VEGF-A in the development of blood vessels in tumors and other tissues undergoing abnormal angiogenesis [27,28], and the development of new anti-VEGF antibodies to counteract neovascularization, especially in advanced cancers or in ocular diseases (i.”
BackgroundPlant Polyphenols as Dietary Antioxidants in Human Health and Disease
Pandey, K. B., & Rizvi, S. I. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9498 · Cited by 3,942
Age-related macular degeneration
Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G., & Wong, T. Y. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60282-7 · Cited by 1,717
Signal transduction by vascular endothelial growth factor receptors
Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson-Welsh, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,635
Phosphorylation of c-jun mediated by MAP kinases
Pulverer, B. J., Kyriakis, J. M., Avruch, J., Nikolakaki, E., & Woodgett, J. R. (1991) · Nature · doi:10.1038/353670a0 · Cited by 1,468
ARPE-19, A Human Retinal Pigment Epithelial Cell Line with Differentiated Properties
DUNN, K. C., AOTAKI-KEEN, A. E., PUTKEY, F. R., & HJELMELAND, L. M. (1996) · Experimental Eye Research · doi:10.1006/exer.1996.0020 · Cited by 1,330
Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., & Karin, M. (1991) · Nature · doi:10.1038/354494a0 · Cited by 789 · cited 3×
“Indeed, the transcriptional activity of c-Jun is increased by phosphorylation of these two serines in the transactivation domain that are mediated by MAP kinases [24,25].”
BackgroundThe Age-Related Eye Disease Study (AREDS)
(1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00031-8 · Cited by 585
Cited by
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review
Wong, K.-H., Nam, H.-Y., Lew, S. Y., Naidu, M. K., David, P. R., Kamalden, T. A., Hadie, S. N. H., & Lim, L. W. (2022) · Pharmaceuticals · doi:10.3390/ph15010101 · Cited by 40
Zeppieri, M., Gagliano, C., D’Esposito, F., Musa, M., Gattazzo, I., Zanella, M. S., Rossi, F. B., Galan, A., & Babighian, S. (2024) · Antioxidants · doi:10.3390/antiox14010006 · Cited by 30
Cao, Y., Li, Y., Gkerdi, A., Reilly, J., Tan, Z., & Shu, X. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220511142817 · Cited by 19
Caveolin-1 Down-Regulation Reduces VEGF-A Secretion Induced by IGF-1 in ARPE-19 Cells
Puddu, A., Sanguineti, R., & Maggi, D. C. (2021) · Life · doi:10.3390/life12010044 · Cited by 14
Sghaier, R., Perus, M., Cornebise, C., Courtaut, F., Scagliarini, A., Olmiere, C., Aires, V., Hermetet, F., & Delmas, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911704 · Cited by 11
Self-citationDatseris, I., Kotronis, C., Datseris, I., Tzanidaki, M.-E., ROUVAS, A. A., & Gouliopoulos, N. (2023) · International Journal of Ophthalmology · doi:10.18240/ijo.2023.09.17 · Cited by 11
Perus, M., Courtaut, F., de Barros, J.-P. P., Aires, V., Hermetet, F., & Delmas, D. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300893 · Cited by 9
Self-citationBurgers, L. D., Li, Y., Michalakis, S., Ciurus, S., Zahler, S., Müller, R., & Fürst, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113174 · Cited by 7
Ren, W., Duan, S., Mei, C., Xie, C., Jiang, L., & Shi, Y. (2023) · Molecules · doi:10.3390/molecules28083500 · Cited by 7
The Recent Advances in the Function and Mechanism of Caveolin-1 in Retinal Neovascularization
Zhang, R., & Dang, Y. (2024) · Current Drug Targets · doi:10.2174/0113894501310201240403065930 · Cited by 3
Mialhe, A., de Barros, J.-P. P., Hermetet, F., Limagne, E., Ghiringhelli, F., Aires, V., & Delmas, D. (2026) · Cells · doi:10.3390/cells15050439 · Cited by 3
Self-citationDong, Y., Li, Y., Zhou, X., Huang, W., Yang, S., Lin, H., Wei, K., Yao, J., Zuo, H., & Zuo, C. (2025) · Current Eye Research · doi:10.1080/02713683.2025.2523916 · Cited by 2
Current Advances in the Combination of Fatty Acids and Resveratrol to Fight Ocular Diseases
Delmas, D., Perus, M., Aires, V., & Hermetet, F. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70037 · Cited by 1
Self-citationFood nutrients and functional components in retinal vascular protection: A mechanism-oriented review
Wu, J., Wang, J., Feng, J., Liu, Y., Wang, Z., Chen, Y., Ding, Z., Yang, W., Xu, W., Niu, X., et al. (2026) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2026.105738
Meng, F., Zhong, Y., Xu, Z., Wang, Y., Qin, Y., & Zhao, J. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.107034
Polyphénols de la vigne et du vin et dégénérescence maculaire liée à l'âge
Cornebise, C. (2023) · theses.fr (ABES) · doi:10.70675/f1f7a166z1bf0z4f73z98b5zb95d153dd838
Self-citationXu, S., Zhuo, Q., Li, J., Li, B., Zhu, W., Xue, Y., Zhang, S., & Zhao, C. (2026) · Microvascular Research · doi:10.1016/j.mvr.2026.104992
Metadata
- Authors
- Courtaut, F., Scagliarini, A., Aires, V., Cornebise, C., Pais de Barros, J.-P., Olmiere, C., & Delmas, D.
- Affiliations
- Inserm (FR)
- Université de Bourgogne Franche-Comté, 21000 Dijon, France
- Laboratoires Thea, 12 Rue Louis-Blériot, 63000 Clermont-Ferrand, France
- Corresponding author
- Delmas, Dominique
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-19
- Volume
- 22
- Issue
- 12
- Pages
- 6590
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8234996
- OpenAlex
- W3174973673
- Cited by
- 17
- References
- 51
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 1
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Agence Nationale de la Recherche (ANR-11-LABX-0021)
- Association Nationale de la Recherche et de la Technologie
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- age-related macular degeneration, VEGF-A, VEGFR2, caveolin-1, omega-3 fatty acids, resveratrol, MAPK signaling, lipid rafts, AP-1 transcription factor, anti-VEGF therapy, dietary intervention
- MeSH terms
- Cell Line, Drug Evaluation, Preclinical, Humans, Macular Degeneration, Retina, Transcription Factor AP-1, MAP Kinase Signaling System, Vascular Endothelial Growth Factor Receptor-2, Caveolin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.